|Articles|March 6, 2014

INC Research, LLC Acquired MEK Consulting

Acquisition provides customers improved access to Middle East and North Africa region as well as Southern Europe

INC Research, LLC has acquired MEK Consulting, a clinical monitoring-focused CRO based in Lebanon with operations in Greece, Turkey and the Middle East and North Africa (MENA) region. Through the acquisition, INC would have access to the over 200 million potential patients in the region.

Read the full release here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content

© photon_photo - © photon_photo - stock.adobe.com

INC Research, LLC Acquired MEK Consulting

Newsletter

Related Content

Drug Repurposing Through AI-Driven In-Silico Clinical Trials

ACT Brief: CNS Trial Expansion, Vaccine Policy Debate, and New Leadership at FDA

Obesity Trials: Scaling Operations for High-Demand Therapeutics

Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework

ACT Brief: Targeted Trial Growth, Site Startup Strains, and Leadership Shake-Up at FDA

Trending on Applied Clinical Trials Online

Drug Repurposing Through AI-Driven In-Silico Clinical Trials

ACT Brief: FDA’s Agentic AI Rollout, Exercise Interventions for Long COVID, and Patient-Centered Evidence Beyond the Trial

Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework

Targeted and Strategy-Driven Clinical Development

CNS and Autoimmune Trials: Growth and Operational Implications